1965
DOI: 10.1016/0024-3205(65)90126-8
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of tyrosine hydroxylase by 3-iodo-L-tyrosine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1966
1966
1985
1985

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…3-Iodo-L-tyrosine is a potent tyrosine hydroxylase inhibitor in vitro (GOLDSTEIN & WEISS 1965). Since inhibition of this enzyme may cause a decrease in catecholamine content of the brain in pheniprazine-treated mice also, we investigated the effect of 3-iodotyrosine on the pheniprazine counteraction of reserpine-induced inhibition of amine uptake.…”
Section: Ma 0-inhibitorsmentioning
confidence: 99%
“…3-Iodo-L-tyrosine is a potent tyrosine hydroxylase inhibitor in vitro (GOLDSTEIN & WEISS 1965). Since inhibition of this enzyme may cause a decrease in catecholamine content of the brain in pheniprazine-treated mice also, we investigated the effect of 3-iodotyrosine on the pheniprazine counteraction of reserpine-induced inhibition of amine uptake.…”
Section: Ma 0-inhibitorsmentioning
confidence: 99%
“…DDC does not seem to be exerting a reserpine-like action in the present experiments because it depletes only noradrenaline whereas reserpine depletes dopamine, noradrenaline and 5-hydroxytryptamine from tissues; furthermore, the 5-hydroxytryptamine content after the injection of DDC remains unchanged and, of even greater significance, the dopamine level increases. Inhibition by 3-iodo-L-tyrosine of the enzyme tyrosine hydroxylase, the enzyme responsible for the ring-hydroxylation of tyrosine to form DOPA in the biosynthesis of noradrenaline, lowers both the dopamine and noradrenaline tissue contents (see also Udenfriend, ZaltzmanNirenberg & Nagatsu, 1965;Goldstein, Anagoste & Nakajima, 1965;Goldstein & Weiss, 1965). DDC (Goldstein et al, 1964) and disulfiram (Goldstein et al, 1964;Musacchio et a!., 1964;Musacchio et al, 1966), however, do not modify the uptake or the binding of noradrenaline, and disulfiram has been shown to be ineffective in releasing noradrenaline from rat hearts (Musacchio et al, 1966).…”
Section: Injections Of Diethyldithiocarbamatementioning
confidence: 99%
“…3-iodo-Tyrosine (3IT), a competitive inhibitor of tyrosine hydroxylase (Goldstein & Weiss, 1965;Ikeda, Levitt& Udenfriend, 1965) at a dose of 200 mg/kg subcutaneously reduces brain levels of noradrenaline and dopamine. Sodium diethyldithiocarbamate (DDC) inhibits dopamine-f-hydroxylase (Goldstein, Anagoste, Lauber & McKereghan, 1964) and DDC (500 mg/kg subcutaneously) decreases noradrenaline levels to a greater degree than 3IT, while increasing dopamine content.…”
Section: Harrogatementioning
confidence: 99%